Joseph Shrager

Publication Details

  • Risk of death from intercurrent disease is not excessively increased by modern postoperative radiotherapy for high-risk resected non-small-cell lung carcinoma.

    Machtay M, Lee JH, Shrager JB, Kaiser LR, Glatstein E. J Clin Oncol. 2001; 19 (19): 3912-7

    Some studies report a high risk of death from intercurrent disease (DID) after postoperative radiotherapy (XRT) for non-small-cell lung cancer (NSCLC). This study determines the risk of DID after modern-technique postoperative XRT.

    PubMedID: 11579111

Stanford Medicine Resources:

Footer Links: